Abbott recalls some Similac, other powder baby formulas due to Salmonella, Cronobacter complaints
Abbott Laboratories said late Thursday it is voluntarily recalling powder baby formulas, including its best-selling Similac, made in one plant in Michigan after it received...
Garmin reports record revenue, beats target
Garmin Ltd. said Wednesday its fourth-quarter net income fell to $286.14 million or $1.48 a share, from $333.55 million, or $1.73 a share, in the...
Extra Space Storage raises dividend by 20%, to lift the dividend yield above its REIT peer group
Shares of Extra Space Storage Inc. rose 0.4% in premarket trading after the real estate investment trust (REIT) that owns and operates self-storage properties raised...
Crocs shares rise after earnings beat, record annual revenue
Crocs Inc. stock rose 4.5% in Wednesday premarket trading after the shoe and accessories company reported fourth-quarter earnings and revenue that beat expectations and gave...
The Trade Desk stock heads higher after upbeat earnings, outlook
Shares of The Trade Desk were up more than 3% in premarket trading Wednesday after the advertising-technology company exceeded expectations with its latest financial results...
Wingstop shares sink after profit and revenue misses expectations
Wingstop Inc. shares sank 6.8% in Wednesday premarket trading after the chicken chain reported fourth-quarter profit and revenue that missed Street expectations. Net income totaled...
Ryder stock rallies after big profit beat, an upbeat outlook and plans for $300 million ASR
Shares of Ryder System Inc. rallied 5.2% in premarket trading Wednesday, after the truck rental company reported fourth-quarter earnings that rose above expectations, provided an...
Economic Report: Coming up: U.S. retail sales
Justin Sullivan/Getty ImagesSales at U.S. retailers are forecast to increase 2.1% in January, according to economists polled by The Wall Street Journal. Consumers likely spent...
Sage’s stock falls 11% on new clinical data for experimental depression drug
Shares of Sage Therapeutics Inc. tumbled 11.2% in premarket trading on Wednesday after Wall Street raised questions about the durability of the experimental treatment for...